Published in NMR Biomed on March 04, 1993
Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease. Am J Physiol Renal Physiol (2006) 1.38
Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (2000) 1.25
Metabolic tumor imaging using magnetic resonance spectroscopy. Semin Oncol (2011) 1.22
pH-titratable superparamagnetic iron oxide for improved nanoparticle accumulation in acidic tumor microenvironments. ACS Nano (2011) 1.21
Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Neoplasia (2001) 1.13
In vivo pH imaging with (99m)Tc-pHLIP. Mol Imaging Biol (2012) 1.09
Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.06
Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Br J Cancer (1998) 1.05
Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors. Clin Cancer Res (2009) 1.02
Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer (1998) 1.02
New frontiers and developing applications in 19F NMR. Prog Nucl Magn Reson Spectrosc (2012) 1.02
Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods. Proc IEEE Inst Electr Electron Eng (2005) 1.02
Brain temperature by Biosensor Imaging of Redundant Deviation in Shifts (BIRDS): comparison between TmDOTP5- and TmDOTMA-. NMR Biomed (2010) 1.01
Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol (2010) 0.97
Fourier transform EPR spectroscopy of trityl radicals for multifunctional assessment of chemical microenvironment. Angew Chem Int Ed Engl (2014) 0.95
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan. NMR Biomed (2012) 0.95
The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer (1995) 0.94
Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner. MAGMA (2014) 0.92
The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion. Br J Cancer (1997) 0.91
Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells. Br J Cancer (1998) 0.89
(15)N Hyperpolarization of Imidazole-(15)N2 for Magnetic Resonance pH Sensing via SABRE-SHEATH. ACS Sens (2016) 0.88
Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments. J Med Chem (2013) 0.86
Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia (2002) 0.82
Involvement of tumor macrophage HIFs in chemotherapy effectiveness: mathematical modeling of oxygen, pH, and glutathione. PLoS One (2014) 0.82
The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions. Proc Natl Acad Sci U S A (2015) 0.81
Stable bioenergetic status despite substantial changes in blood flow and tissue oxygenation in a rat tumour. Br J Cancer (1994) 0.81
Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors. Cancer Res (2015) 0.80
MR - eyes for cancer: looking within an impenetrable disease. NMR Biomed (2013) 0.79
pH-Sensitive MR Responses Induced by Dendron-Functionalized SPIONs. J Phys Chem C Nanomater Interfaces (2012) 0.78
(31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results. MAGMA (2016) 0.77
Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children. Eur J Radiol (2013) 0.77
In vivo (31)P magnetic resonance spectroscopy and morphometric analysis of the perfused vascular architecture of human glioma xenografts in nude mice. Br J Cancer (1997) 0.76
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts. Sci Rep (2016) 0.75
Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression. Sci Rep (2017) 0.75
Quality assessment in health. Br Med J (Clin Res Ed) (1984) 8.78
Guidelines for the welfare and use of animals in cancer research. Br J Cancer (2010) 6.97
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev (2000) 5.16
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res (1999) 3.23
The Osteopaths Bill. BMJ (1993) 3.16
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res (1997) 2.96
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Are cancer cells acidic? Br J Cancer (1991) 2.72
Causes and consequences of tumour acidity and implications for treatment. Mol Med Today (2000) 2.44
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2003) 2.44
White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology (2006) 2.42
Aortic morphology following endovascular repair of acute and chronic type B aortic dissection: implications for management. Eur J Vasc Endovasc Surg (2008) 2.32
Funduscopy: a forgotten art? Postgrad Med J (1999) 2.28
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. Blood (1989) 2.17
Oral candidiasis. Postgrad Med J (2002) 2.02
Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (1984) 1.98
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol (1992) 1.97
Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry (2009) 1.97
Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol (1990) 1.94
Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol (1999) 1.93
District general managers: should they be medically qualified? Br J Hosp Med (1989) 1.93
Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS (1992) 1.93
ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity (2001) 1.92
Induction of the prospective neural crest of Xenopus. Development (1995) 1.91
Biogenesis of mitochondria: the mitochondrial gene (aap1) coding for mitochondrial ATPase subunit 8 in Saccharomyces cerevisiae. Nucleic Acids Res (1983) 1.89
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88
In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med (1999) 1.86
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res (2001) 1.82
Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer (1999) 1.79
Assessment of cellular telephone and other radio frequency exposure for epidemiologic research. Epidemiology (1996) 1.78
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
A regional psychiatric rehabilitation hospital. Br J Psychiatry (1965) 1.70
Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1995) 1.62
The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia (2012) 1.61
Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology (1999) 1.60
Cognition in early human immunodeficiency virus infection. Arch Neurol (1990) 1.59
Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probes. NMR Biomed (1999) 1.58
5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer (1984) 1.56
Vagus nerve stimulation for complex partial seizures: surgical technique, safety, and efficacy. J Neurosurg (1993) 1.55
Dynamic asymmetry of phosphocreatine concentration and O(2) uptake between the on- and off-transients of moderate- and high-intensity exercise in humans. J Physiol (2002) 1.49
Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed (2001) 1.48
Inferences from pulmonary O2 uptake with respect to intramuscular [phosphocreatine] kinetics during moderate exercise in humans. J Physiol (1999) 1.48
Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol (1992) 1.45
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer (2000) 1.44
Hospital doctors' assessment of baseline spirometry. Postgrad Med J (1998) 1.44
BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging (2001) 1.44
Cognition and immune function in HIV-1 infection. AIDS (1992) 1.41
Massive pulmonary emboli associated with olanzapine. Ir Med J (2008) 1.41
Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions. Biochem J (1978) 1.40
Radiographic guided epidural placement. Anaesthesia (2003) 1.39
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Hyperparathyroid crisis and posterior mediastinal parathyroid adenoma: a case for preoperative localization. Surgery (1993) 1.38
Does the chronic psychiatric patient understand plain English? Br J Psychiatry (1972) 1.38
Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem Pharmacol (1999) 1.38
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br J Cancer (2009) 1.36
Mechanisms of global support and posttraumatic enophthalmos: I. The anatomy of the ligament sling and its relation to intramuscular cone orbital fat. Plast Reconstr Surg (1986) 1.36
Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature (1987) 1.35
Telomeric structure in cells with chromosome end associations. Chromosoma (1993) 1.34
The influence of vasopressin and related peptides on glycogen phosphorylase activity and phosphatidylinositol metabolism in hepatocytes. Biochem J (1979) 1.33
Effects of fructose on the energy metabolism and acid-base status of the perfused starved-rat liver. A 31phosphorus nuclear magnetic resonance study. Biochem J (1980) 1.32
Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo. Anticancer Res (2001) 1.32
Polynucleotide synthesis and the genetic code. Cold Spring Harb Symp Quant Biol (1966) 1.31
Long-term growth of malignant thymocytes in vitro. Blood (1989) 1.28
Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging (1999) 1.27
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol (2003) 1.27
Simultaneous determination of muscle 31P and O2 uptake kinetics during whole body NMR spectroscopy. J Appl Physiol (1985) (1999) 1.27
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol (1996) 1.26
The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol (2007) 1.26
Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett (1992) 1.26
Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (2000) 1.25
Glycogen phosphorylase, glucose output and vasoconstriction in the perfused rat liver. Concentration-dependence of actions of adrenaline, vasopressin and angiotensin II. Biochem J (1976) 1.25
Magnetic resonance neurography. Lancet (1993) 1.23
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer (2003) 1.23
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science (1986) 1.21
Classification of brain tumours using short echo time 1H MR spectra. J Magn Reson (2004) 1.21
Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions. Biochem J (1978) 1.20
31P-NMR investigation of solid tumours in the living rat. Biosci Rep (1981) 1.20
Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem Int (1990) 1.19
Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS. Magn Reson Med (2003) 1.19
Mitochondrial gene defects in patients with NIDDM. Diabetologia (1994) 1.18
The value of respiratory tract bacteriology in pneumococcal pneumonia among Navajo Indians. Am Rev Respir Dis (1974) 1.17
The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer (1997) 1.16